Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 6/20 | 0.62 |
| ▸ | NPC1 | O15118 | 5/20 | 0.62 |
| ▸ | GAA | P10253 | 5/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.60 |
| ▸ | MAPT | P10636 | 4/20 | 0.60 |
| ▸ | LMNA | P02545 | 1/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.58 |
| ▸ | MEN1 | O00255 | 3/20 | 0.58 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.58 |
| ▸ | TSHR | P16473 | 2/20 | 0.58 |
| ▸ | TP53 | P04637 | 1/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | FABP1 | P07148 | 1/20 | 0.51 |
| ▸ | P2RY14 | Q15391 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13308506 | 0.85 | ESR1 (0.54) | RAB9ANPC1GAASMN1; SMN2ALDH1A1 | |
| SCHEMBL1947842 | 0.83 | NPC1 (0.80) | RAB9ANPC1GAASMN1; SMN2ALDH1A1 | |
| SCHEMBL7232750 | 0.83 | KDM4E (0.74) | RAB9ANPC1GAAALDH1A1MAPT | |
| SCHEMBL10943445 | 0.82 | RAB9A (0.88) | RAB9ANPC1GAASMN1; SMN2ALDH1A1 | |
| SCHEMBL5879030 | 0.82 | RAB9A (0.88) | RAB9ANPC1GAASMN1; SMN2ALDH1A1 | |
| SCHEMBL31114086 | 0.80 | RAB9A (0.60) | RAB9ANPC1GAASMN1; SMN2ALDH1A1 | |
| SCHEMBL6673464 | 0.79 | RAB9A (0.59) | RAB9ANPC1GAASMN1; SMN2ALDH1A1 | |
| SCHEMBL16270607 | 0.79 | P2RY14 (0.75) | RAB9ANPC1GAASMN1; SMN2MAPT | |
| SCHEMBL31114172 | 0.79 | RAB9A (0.55) | RAB9ANPC1GAASMN1; SMN2ALDH1A1 | |
| SCHEMBL2350063 | 0.79 | MAPK14 (0.64) | RAB9ANPC1GAASMN1; SMN2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120088888-A1 | POLYIMIDE PRECURSOR, POLYIMIDE, AND LIQUID CRYSTAL ALIGNING AGENT | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2012-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120088888-A1 | POLYIMIDE PRECURSOR, POLYIMIDE, AND LIQUID CRYSTAL ALIGNING AGENT | PUF60, F13A1, F12 | RAB9A 1123/4885NPC1 4839/4885GAA 4561/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.